Similar results were also obtained in p53-mutated human pancreatic cancer MiaPaCa-2 cells (Nakamura et al., manuscript in preparation), indicating that RUNX2 depletion-mediated enhancement of GEM sensitivity may not be restricted to p53-deficient AsPC-1 cells. This evidence concerns the gene TP53 and familial pancreatic carcinoma.